Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma
Clinical trial NCT01767454 · COMPLETED
Trial details
- NCT number
- NCT01767454
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-12
- Primary completion
- 2015-09-04
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.